DOTFM-NDEPA

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

DOTFM-NDEPA
File:DOTFM-NDEPA.svg
Clinical data
Other namesNDEPA-DOTFM; "Compound ko1"[1]
Drug classPossible serotonin 5-HT2A receptor modulator[1]
ATC code
  • None
Identifiers
CAS Number
E number{{#property:P628}}
CompTox Dashboard (EPA)
  • {{#property:P3117}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC19H29F3N2O3
Molar mass390.447 g·mol−1
3D model (JSmol)
  • C(F)(F)(F)C1C=C(C(=CC=1OC)CC(C)N(CCC(=O)N(CC)CC)[H])OC
  • InChI=1S/C19H29F3N2O3/c1-6-24(7-2)18(25)8-9-23-13(3)10-14-11-17(27-5)15(19(20,21)22)12-16(14)26-4/h11-13,23H,6-10H2,1-5H3
  • Key:XQPSNZUNPOQENQ-UHFFFAOYSA-N

DOTFM-NDEPA is a chemical compound of the phenethylamine, DOx, and NDEPA families.[1] It is the N-(N,N-diethylpropylamide) (NDEPA) derivative of the psychedelic drug DOTFM.[1] The drug can also be thought of as a derivative of DOTFM with an LSD-like N,N-diethylamide moiety.[1] A quantitative structure–activity relationship (QSAR) predicted that DOTFM-NDEPA would bind with high affinity to the serotonin 5-HT2A receptor.[1] Its predicted affinity (Ki) was 22 nM.[1] DOTFM-NDEPA was first described in the scientific literature by 1999.[1]

See also

[edit | edit source]

References

[edit | edit source]
  1. ^ a b c d e f g h Lua error in Module:Citation/CS1/Configuration at line 2172: attempt to index field '?' (a nil value).
[edit | edit source]